{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:56:54Z","timestamp":1794049014443,"version":"4.8.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T00:00:00Z","timestamp":1541635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T00:00:00Z","timestamp":1541635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cholestasis impairs liver regeneration following partial liver resection (PHx). Bile acid receptor farnesoid X-receptor (FXR) is a key mediator of liver regeneration. The effects of FXR agonist obeticholic acid (OCA) on liver (re)growth were therefore studied in cholestatic rats. Animals underwent sham surgery or reversible bile duct ligation (rBDL). PHx with concurrent internal biliary drainage was performed 7 days after rBDL. Animals were untreated or received OCA (10\u2009mg\/kg\/day) per oral gavage from rBDL until sacrifice. After 7 days of OCA treatment, dry liver weight increased in the rBDL\u2009+\u2009OCA group, indicating OCA-mediated liver growth. Enhanced proliferation in the rBDL\u2009+\u2009OCA group prior to PHx concurred with a rise in Ki67-positive hepatocytes, elevated hepatic <jats:italic>Ccnd1<\/jats:italic> and <jats:italic>Cdc25b<\/jats:italic> expression, and an induction of intestinal fibroblast growth factor 15 expression. Liver regrowth after PHx was initially stagnant in the rBDL\u2009+\u2009OCA group, possibly due to hepatomegaly prior to PHx. OCA increased hepatobiliary injury markers during BDL, which was accompanied by upregulation of the bile salt export pump. There were no differences in histological liver injury. In conclusion, OCA induces liver growth in cholestatic rats prior to PHx but exacerbates biliary injury during cholestasis, likely by forced pumping of bile acids into an obstructed biliary tree.<\/jats:p>","DOI":"10.1038\/s41598-018-33070-1","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T11:14:43Z","timestamp":1541157283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis"],"prefix":"10.1038","volume":"8","author":[{"given":"Rowan F.","family":"van Golen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim B.","family":"Olthof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00ebl A.","family":"Lionarons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan J.","family":"Reiniers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindy K.","family":"Alles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehra","family":"Uz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent","family":"Ergin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk R.","family":"de Waart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrie","family":"Maas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Verheij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W. Olde","family":"Damink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1597-572X","authenticated-orcid":false,"given":"Frank G.","family":"Schaap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"van Gulik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Heger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,8]]},"reference":[{"key":"33070_CR1","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/nrm1489","volume":"5","author":"R Taub","year":"2004","unstructured":"Taub, R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 5, 836\u2013847 (2004).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"33070_CR2","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/bjs.7194","volume":"97","author":"VE de Meijer","year":"2010","unstructured":"de Meijer, V. E., Kalish, B. T., Puder, M. & Ijzermans, J. N. Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br J Surg 97, 1331\u20131339 (2010).","journal-title":"Br J Surg"},{"key":"33070_CR3","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/bjs.8950","volume":"100","author":"O Farges","year":"2013","unstructured":"Farges, O. et al. Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. Br J Surg 100, 274\u2013283 (2013).","journal-title":"Br J Surg"},{"key":"33070_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jamcollsurg.2016.03.035","volume":"223","author":"JK Wiggers","year":"2016","unstructured":"Wiggers, J. K. et al. Postoperative Mortality after Liver Resection for Perihilar Cholangiocarcinoma: Development of a Risk Score and Importance of Biliary Drainage of the Future Liver Remnant. J Am Coll Surg 223, 321\u2013331.e1 (2016).","journal-title":"J Am Coll Surg"},{"key":"33070_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrgastro.2013.151","volume":"11","author":"FG Schaap","year":"2013","unstructured":"Schaap, F. G., Trauner, M. & Jansen, P. L. M. Bile acid receptors as targets for drug development. Nature Reviews Gastroenterology & Hepatology 11, 55\u201367 (2013).","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"33070_CR6","doi-asserted-by":"publisher","first-page":"e97426","DOI":"10.1371\/journal.pone.0097426","volume":"9","author":"WE Naugler","year":"2014","unstructured":"Naugler, W. E. Bile acid flux is necessary for normal liver regeneration. PLoS One 9, e97426 (2014).","journal-title":"PLoS One"},{"key":"33070_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1126\/science.1121435","volume":"312","author":"W Huang","year":"2006","unstructured":"Huang, W. et al. Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 312, 233\u2013236 (2006).","journal-title":"Science"},{"key":"33070_CR8","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/hep.26463","volume":"58","author":"N P\u00e9an","year":"2013","unstructured":"P\u00e9an, N. et al. The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice. Hepatology 58, 1451\u20131460 (2013).","journal-title":"Hepatology"},{"key":"33070_CR9","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1136\/gutjnl-2012-302945","volume":"62","author":"I Uriarte","year":"2013","unstructured":"Uriarte, I. et al. Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice. Gut 62, 899\u2013910 (2013).","journal-title":"Gut"},{"key":"33070_CR10","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1136\/gutjnl-2014-307874","volume":"64","author":"S Padrissa-Alt\u00e9s","year":"2015","unstructured":"Padrissa-Alt\u00e9s, S. et al. Control of hepatocyte proliferation and survival by Fgf receptors is essential for liver regeneration in mice. Gut 64, 1444\u20131453 (2015).","journal-title":"Gut"},{"key":"33070_CR11","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/bjs.8906","volume":"99","author":"R Otao","year":"2012","unstructured":"Otao, R. et al. External biliary drainage and liver regeneration after major hepatectomy. Br J Surg 99, 1569\u20131574 (2012).","journal-title":"Br J Surg"},{"key":"33070_CR12","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa1509840","volume":"375","author":"F Nevens","year":"2016","unstructured":"Nevens, F. et al. A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis. N Engl J Med 375, 631\u2013643 (2016).","journal-title":"N Engl J Med"},{"key":"33070_CR13","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1002\/bjs.10466","volume":"104","author":"PB Olthof","year":"2017","unstructured":"Olthof, P. B. et al. Effect of obeticholic acid on liver regeneration following portal vein embolization in an experimental model. Br J Surg 104, 590\u2013599 (2017).","journal-title":"Br J Surg"},{"key":"33070_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/srep31829","volume":"6","author":"DA Lionarons","year":"2016","unstructured":"Lionarons, D. A. et al. Simple steatosis sensitizes cholestatic rats to liver injury and dysregulates bile salt synthesis and transport. Scientific Reports 6, 31829 (2016).","journal-title":"Scientific Reports"},{"issue":"4","key":"33070_CR15","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jhep.2009.05.015","volume":"51","author":"Hendrik A. Marsman","year":"2009","unstructured":"Marsman, H. A., Al-Saady, R. L., Heger, M. & van Gulik, T. M. How reproducible are rat steatosis models using high-fat diets?. J Hepatol 51, 822\u20133; author reply 824 (2009).","journal-title":"Journal of Hepatology"},{"key":"33070_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.surg.2008.03.030","volume":"144","author":"JJ Kloek","year":"2008","unstructured":"Kloek, J. J., Marsman, H. A., van Vliet, A. K., Gouma, D. J. & van Gulik, T. M. Biliary drainage attenuates postischemic reperfusion injury in the cholestatic rat liver. Surgery 144, 22\u201331 (2008).","journal-title":"Surgery"},{"key":"33070_CR17","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/bjs.9059","volume":"100","author":"HA Marsman","year":"2013","unstructured":"Marsman, H. A. et al. Hepatic regeneration and functional recovery following partial liver resection in an experimental model of hepatic steatosis treated with omega-3 fatty acids. Br J Surg 100, 674\u2013683 (2013).","journal-title":"Br J Surg"},{"key":"33070_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1872-034X.2009.00579.x","volume":"40","author":"JJ Kloek","year":"2010","unstructured":"Kloek, J. J. et al. Cholestasis enhances liver ischemia\/reperfusion-induced coagulation activation in rats. Hepatol Res 40, 204\u2013215 (2010).","journal-title":"Hepatol Res"},{"key":"33070_CR19","first-page":"180","volume":"1","author":"PB Olthof","year":"2015","unstructured":"Olthof, P. B. et al. IL-23 and IL-17 are not involved in hepatic ischemia reperfusion injury in mouse and man. J Clin Transl Res 1, 180\u2013189 (2015).","journal-title":"J Clin Transl Res"},{"key":"33070_CR20","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/hep.28373","volume":"63","author":"N Vartak","year":"2016","unstructured":"Vartak, N. et al. Cholestasis-induced adaptive remodeling of interlobular bile ducts. Hepatology 63, 951\u2013964 (2016).","journal-title":"Hepatology"},{"key":"33070_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/019262338801600103","volume":"16","author":"DL Rothacker","year":"1988","unstructured":"Rothacker, D. L., Kanerva, R. L., Wyder, W. E., Alden, C. L. & Maurer, J. K. Effects of variation of necropsy time and fasting on liver weights and liver components in rats. Toxicologic pathology 16, 22\u201326 (1988).","journal-title":"Toxicologic pathology"},{"key":"33070_CR22","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1002\/hep.25905","volume":"56","author":"L Zhang","year":"2012","unstructured":"Zhang, L. et al. Promotion of liver regeneration\/repair by farnesoid X receptor in both liver and intestine in mice. Hepatology 56, 2336\u20132343 (2012).","journal-title":"Hepatology"},{"key":"33070_CR23","doi-asserted-by":"publisher","first-page":"16881","DOI":"10.1073\/pnas.252570299","volume":"99","author":"X Wang","year":"2002","unstructured":"Wang, X., Kiyokawa, H., Dennewitz, M. B. & Costa, R. H. The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration. Proc Natl Acad Sci USA 99, 16881\u201316886 (2002).","journal-title":"Proc Natl Acad Sci USA"},{"key":"33070_CR24","doi-asserted-by":"publisher","first-page":"27277","DOI":"10.1074\/jbc.M704244200","volume":"282","author":"BC Lin","year":"2007","unstructured":"Lin, B. C., Wang, M., Blackmore, C. & Desnoyers, L. R. Liver-specific activities of FGF19 require Klotho beta. J Biol Chem 282, 27277\u201327284 (2007).","journal-title":"J Biol Chem"},{"key":"33070_CR25","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/hep.23708","volume":"52","author":"V Triantis","year":"2010","unstructured":"Triantis, V., Saeland, E., Bijl, N., Oude-Elferink, R. P. & Jansen, P. L. Glycosylation of fibroblast growth factor receptor 4 is a key regulator of fibroblast growth factor 19-mediated down-regulation of cytochrome P450 7A1. Hepatology 52, 656\u2013666 (2010).","journal-title":"Hepatology"},{"key":"33070_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/hep.1840180114","volume":"18","author":"N Yamanaka","year":"1993","unstructured":"Yamanaka, N. et al. Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function. Hepatology 18, 79\u201385 (1993).","journal-title":"Hepatology"},{"key":"33070_CR27","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0016-5085(03)01068-0","volume":"125","author":"M Wagner","year":"2003","unstructured":"Wagner, M. et al. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology 125, 825\u2013838 (2003).","journal-title":"Gastroenterology"},{"key":"33070_CR28","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/hep.22771","volume":"49","author":"FG Schaap","year":"2009","unstructured":"Schaap, F. G., van der Gaag, N. A., Gouma, D. J. & Jansen, P. L. High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis. Hepatology 49, 1228\u20131235 (2009).","journal-title":"Hepatology"},{"key":"33070_CR29","doi-asserted-by":"publisher","first-page":"G1124","DOI":"10.1152\/ajpgi.00539.2005","volume":"290","author":"JL Boyer","year":"2006","unstructured":"Boyer, J. L. et al. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents. Am J Physiol Gastrointest Liver Physiol 290, G1124\u2013G1130 (2006).","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"33070_CR30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jhep.2011.05.031","volume":"56","author":"MG Fern\u00e1ndez-Barrena","year":"2012","unstructured":"Fern\u00e1ndez-Barrena, M. G. et al. Lack of Abcc3 expression impairs bile-acid induced liver growth and delays hepatic regeneration after partial hepatectomy in mice. J Hepatol 56, 367\u2013373 (2012).","journal-title":"J Hepatol"},{"key":"33070_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1124\/jpet.114.214650","volume":"350","author":"A Roda","year":"2014","unstructured":"Roda, A. et al. Semisynthetic bile acid FXR and TGR5 agonists: physicochemical properties, pharmacokinetics, and metabolism in the rat. J Pharmacol Exp Ther 350, 56\u201368 (2014).","journal-title":"J Pharmacol Exp Ther"},{"key":"33070_CR32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jhep.2013.08.015","volume":"60","author":"J Weerachayaphorn","year":"2014","unstructured":"Weerachayaphorn, J. et al. Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice. J Hepatol 60, 160\u2013166 (2014).","journal-title":"J Hepatol"},{"key":"33070_CR33","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1172\/JCI18945","volume":"112","author":"Y Liu","year":"2003","unstructured":"Liu, Y. et al. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J Clin Invest 112, 1678\u20131687 (2003).","journal-title":"J Clin Invest"},{"key":"33070_CR34","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1053\/j.gastro.2015.05.043","volume":"149","author":"WE Naugler","year":"2015","unstructured":"Naugler, W. E. et al. Fibroblast Growth Factor Signaling Controls Liver Size in Mice With Humanized Livers. Gastroenterology 149, 728\u2013740.e15 (2015).","journal-title":"Gastroenterology"},{"key":"33070_CR35","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.cmet.2014.05.020","volume":"20","author":"S Li","year":"2014","unstructured":"Li, S. et al. Cytoplasmic Tyrosine Phosphatase Shp2 Coordinates Hepatic Regulation of Bile Acid and FGF15\/19 Signaling to Repress Bile Acid Synthesis. Cell Metab 20, 320\u2013332 (2014).","journal-title":"Cell Metab"},{"key":"33070_CR36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","volume":"2","author":"T Inagaki","year":"2005","unstructured":"Inagaki, T. et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab 2, 217\u2013225 (2005).","journal-title":"Cell Metab"},{"key":"33070_CR37","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1124\/dmd.113.055772","volume":"42","author":"D Keppler","year":"2014","unstructured":"Keppler, D. The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia. Drug Metab Dispos 42, 561\u2013565 (2014).","journal-title":"Drug Metab Dispos"},{"key":"33070_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1056\/NEJM198307213090305","volume":"309","author":"JS Weiss","year":"1983","unstructured":"Weiss, J. S. et al. The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia. N Engl J Med 309, 147\u2013150 (1983).","journal-title":"N Engl J Med"},{"key":"33070_CR39","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1053\/j.gastro.2011.10.028","volume":"142","author":"S Modica","year":"2012","unstructured":"Modica, S. et al. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis. Gastroenterology 142, 355\u201365.e1-4 (2012).","journal-title":"Gastroenterology"},{"key":"33070_CR40","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.surg.2016.12.014","volume":"162","author":"PB Olthof","year":"2017","unstructured":"Olthof, P. B. et al. Hepatic parenchymal transection increases liver volume but not function after portal vein embolization in rabbits. Surgery 162, 732\u201341 (2017).","journal-title":"Surgery"},{"key":"33070_CR41","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1002\/hep.25918","volume":"56","author":"P Borude","year":"2012","unstructured":"Borude, P. et al. Hepatocyte-specific deletion of farnesoid X receptor delays but does not inhibit liver regeneration after partial hepatectomy in mice. Hepatology 56, 2344\u20132352 (2012).","journal-title":"Hepatology"},{"key":"33070_CR42","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/hep.28257","volume":"63","author":"M Zhou","year":"2015","unstructured":"Zhou, M. et al. Engineered FGF19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice. Hepatology 63, 914\u2013929 (2015).","journal-title":"Hepatology"},{"key":"33070_CR43","doi-asserted-by":"publisher","first-page":"247ra100","DOI":"10.1126\/scitranslmed.3009098","volume":"6","author":"J Luo","year":"2014","unstructured":"Luo, J. et al. A nontumorigenic variant of FGF19 treats cholestatic liver diseases. Sci Transl Med 6, 247ra100 (2014).","journal-title":"Sci Transl Med"},{"key":"33070_CR44","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1136\/gutjnl-2016-312975","volume":"66","author":"G Alvarez-Sola","year":"2017","unstructured":"Alvarez-Sola, G. et al. Fibroblast growth factor 15\/19 (FGF15\/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration. Gut 66, 1818\u20131828 (2017).","journal-title":"Gut"},{"key":"33070_CR45","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","volume":"62","author":"U Beuers","year":"2015","unstructured":"Beuers, U., Trauner, M., Jansen, P. & Poupon, R. New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond. J Hepatol 62, S25\u2013S37 (2015).","journal-title":"J Hepatol"},{"key":"33070_CR46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jhep.2016.02.040","volume":"65","author":"C Tschuor","year":"2016","unstructured":"Tschuor, C. et al. Constitutive androstane receptor (Car)-driven regeneration protects liver from failure following tissue loss. Journal of Hepatology 65, 66\u201374 (2016).","journal-title":"Journal of Hepatology"},{"key":"33070_CR47","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.cub.2012.05.016","volume":"22","author":"Y Miyaoka","year":"2012","unstructured":"Miyaoka, Y. et al. Hypertrophy and unconventional cell division of hepatocytes underlie liver regeneration. Curr Biol 22, 1166\u20131175 (2012).","journal-title":"Curr Biol"},{"key":"33070_CR48","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1053\/j.gastro.2008.12.040","volume":"136","author":"E D\u2019Aldebert","year":"2009","unstructured":"D\u2019Aldebert, E. et al. Bile Salts Control the Antimicrobial Peptide Cathelicidin Through Nuclear Receptors in the Human Biliary Epithelium. Gastroenterology 136, 1435\u20131443 (2009).","journal-title":"Gastroenterology"},{"key":"33070_CR49","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/gut.2010.212159","volume":"60","author":"RM Gadaleta","year":"2011","unstructured":"Gadaleta, R. M. et al. Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease. Gut 60, 463\u2013472 (2011).","journal-title":"Gut"},{"key":"33070_CR50","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","volume":"385","author":"BA Neuschwander-Tetri","year":"2014","unstructured":"Neuschwander-Tetri, B. A. et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet 385, 956\u2013965 (2014).","journal-title":"Lancet"},{"key":"33070_CR51","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1056\/NEJMc1611913","volume":"375","author":"RF Van Golen","year":"2016","unstructured":"Van Golen, R. F. Obeticholic Acid in Primary Biliary Cholangitis. N Engl J Med 375, e41 (2016).","journal-title":"N Engl J Med"},{"issue":"5","key":"33070_CR52","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1097\/SLA.0b013e3182733f09","volume":"256","author":"Lisette T. Hoekstra","year":"2012","unstructured":"Hoekstra, L. T. et al. Tumor progression after preoperative portal vein embolization. Ann Surg 256, 812\u20137; discussion 817\u20138 (2012).","journal-title":"Annals of Surgery"},{"key":"33070_CR53","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jhep.2008.08.015","volume":"50","author":"HK Ho","year":"2009","unstructured":"Ho, H. K. et al. Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention. J Hepatol 50, 118\u2013127 (2009).","journal-title":"J Hepatol"},{"key":"33070_CR54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1756-8722-4-41","volume":"4","author":"J Dai","year":"2011","unstructured":"Dai, J. et al. Impact of bile acids on the growth of human cholangiocarcinoma via FXR. J Hematol Oncol 4, 41 (2011).","journal-title":"J Hematol Oncol"},{"key":"33070_CR55","doi-asserted-by":"publisher","first-page":"9589","DOI":"10.1158\/0008-5472.CAN-08-1791","volume":"68","author":"S Modica","year":"2008","unstructured":"Modica, S., Murzilli, S., Salvatore, L., Schmidt, D. R. & Moschetta, A. Nuclear bile acid receptor FXR protects against intestinal tumorigenesis. Cancer Res 68, 9589\u20139594 (2008).","journal-title":"Cancer Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33070-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33070-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33070-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T11:16:49Z","timestamp":1671621409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33070-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,8]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["33070"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-33070-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,8]]},"assertion":[{"value":"15 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16529"}}